跳至主要内容
临床试验/TCTR20210416002
TCTR20210416002招募中3 期

A double-blind split-face randomized controlled trial of the efficacy of 2% Curcuma aeruginosa Roxb. extract-containing cream compared with 2% ketoconazole cream in facial seborrheic dermatitis

Research Administration Section, Faculty of Medicine, Thammasat University0 个研究点目标入组 42 人开始时间: 2021年4月16日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • facial seborrheic dermatitis

排除标准

  • 1. Subjects with any untreated or uncontrolled dermatitis on the face, 2. severe co-morbidity, 3. suspected allergy to any study medication, 4. pregnant and lactating women, 5. Subjects who used topical agents(except bland emollients) on the face < 2 weeks before study was initiated, 6. Subjects who had used systemic antifungal agents for > 1 month

研究者

发起方
Research Administration Section, Faculty of Medicine, Thammasat University

相似试验